systemic absorption of dienestrol cream
side effects
dienestrol
estrogen therapy
cases of oral pigmentation
ischemic colitis
gastrointestinal effects
oral therapy
nausea
vomiting
studies
fold increase in gallbladder disease in postmenopausal women
taking oral estrogen therapy
number of studies
risk of endometrial carcinoma
administration of progestins in combination with estrogen therapy
increased risk of breast cancer
estrogens
several studies
long-term estrogen therapy
increased risk of breast cancer
meta analysis of studies
epidemiological data
modest risk increase
long-term hormone replacement therapy
hrt
study of swedish women
increase in the relative risk of breast cancer
risk
increasing duration of estrogen therapy
study
women with more
years of estrogen use
greater relative risk of breast cancer than controls
study
examined use of a variety of estrogen preparations of which estradiol
addition
women
progestins
decreased risk of breast cancer
higher risk
toronto breast cancer study
women
unopposed conjugated estrogens for less than years
increased risk of breast cancer
study
increase in the risk of breast cancer for women
conjugated estrogens for more than years
case-control surveillance study
evidence that the use of unopposed
unopposed conjugated estrogens
risk of breast cancer
long duration of use
long latent intervals
possibility of a modest increase
doubling
nurses
health study
increased risk of breast cancer in women
taking estrogen replacement therapy
risk
concurrent use of progestins
study
greater risk
advanced age
prolonged duration of hormonal therapy
study of middle-aged women in the puget sound area
whole
use of estrogen with progestin hrt
hormone replacement therapy
increased risk of breast cancer in middle-aged women
prospective cohort study
years
women by gapstur
histology of the breast cancer in women
hrt
association
duration
hrt use
incidence of ductal carcinoma
invasive ductal/lobular carcinoma
duration
hrt use
risk of invasive carcinoma with a favorable prognosis
relative risk
rr
confidence interval
ci
hrt
yrs
rr
ci
hrt
> yrs
p
relative risks of invasive carcinoma with a favorable prognosis for current users
age
other risk factors
ci
yrs
ci
> yrs
risk of invasive ductal
lobular carcinoma for current users
yrs
rr
ci
oncologic side effects
unopposed estrogen therapy
increased risk of endometrial carcinoma in patients with an intact uterus
increased risk of breast cancer
effects of estrogen therapy
reducing
reducing cardiovascular risk
beneficial alterations in lipid profiles in treated women
reported effects of estrogens on cardiovascular activity
alterations in lipid profiles in treated women
reducing
reducing cardiovascular risks
data
estrogen use
blood pressure
patients
receiving high doses
blood pressure
change
addition
noncontraceptive use of estrogens in young women
smokers
risk of nonfatal myocardial infarction
other studies
increased risk of myocardial infarction
cardiovascular risks
estrogen therapy
studies
unopposed estrogen therapy
risk of coronary heart disease
combination therapy with a progestin
coronary risk
extent of risk reduction with combination therapy
data
combination therapy
overall rate of coronary heart disease in postmenopausal women with established coronary disease
metabolic side effects
favorable alterations in plasma lipid profiles
hdl
cholesterol
ldl levels
estrogen therapy
increase in serum triglyceride levels
pancreatitis in patients with familial lipoprotein
metabolic defects
hypercalcemia
patients with breast cancer
bone metastases
aggravation of porphyria
hdl
ldl
total cholesterol levels
estrogen therapy
triglyceride levels
dramatic elevations in triglyceride levels
lesser extent
cholesterol levels
hepatic side effects
rare cases of focal nodular hyperplasia
liver cell adenomas
hepatic hemangiomas
well-differentiated hepatocellular carcinomas
reports of hepatic tumors
women
taking long-term oral contraceptives
tumors
women
taking isolated estrogen therapy
hematologic side effects of hypercoagulability
clinical significance of such hypercoagulability in postmenopausal women
taking estrogens
hypersensitivity reactions
anaphylaxis
association with estrogens
dyes
conjugated estrogen formulations
investigators
estrogen therapy
risk
fibrocystic breast disease
estrogens
degree of fluid retention
mastodynia
psychiatric effects of estrogen use
case reports of rapid mood cycling in patients with severe depression
nervous system
side effects
estrogen therapy
migraine
dizziness
mental depression
case of chorea
association
conjugated estrogen therapy
alterations in libido
genitourinary side effects
abnormal uterine bleeding
bleeding
endometrial carcinoma
addition
estrogens
size
preexisting
preexisting uterine leiomyomata
several cases of pseudoincontinence
excessive vaginal discharge
patients as urinary incontinence
post-operative estrogens
dermatologic side effects
chloasma
melasma
following discontinuation of estrogen therapy
scalp hair loss
hirsutism
erythema nodosum
hemorrhagic eruptions
endocrine effects
decreased fasting plasma glucose
estrogen use
increased levels of thyroxin-binding globulin
increase in total thyroid serum levels
decrease in resin uptake of t
free thyroid hormone levels
ocular side effects of estrogen therapy
alterations in corneal curvature
contact lens discomfort
side effects of ortho dienestrol
fda
healthcare professional for medical advice